Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

DreaMed Diabetes Deploys Diabetes Data Management and Clinical Decision Support Device Into Patients’ Electronic Medical Records at Yale New Haven Health

DreaMed Diabetes, a developer of AI-based diabetes care solutions, partnered with Yale New Haven Health System (YNHHS) Center for Health Care Innovation and successfully deployed DreaMed’s endo.digital clinical decision support system as a fully integrated component of Northeast Medical Group’s (NEMG) EMR workflow. NEMG, is a not-for-profit, multispecialty medical foundation and part of YNHHS. This achievement is the first time in the industry that a diabetes clinical decision support system has been deployed as an integrated component of the patients’ electronic medical records, which allows all providers in the patients’ care continuum to provide expert-level diabetes care.

 

“My organization deals with many technology vendors. Care for patients with diabetes adds to this challenge due to all the disparate diabetes devices required for these patients. This new technology will not only improve clinical operations but reduce the need for multiple integrations and installations by the IT team.”

Endo.digital supports all aspects of the diabetes care pathway. This includes diabetes device data acquisition, processing patients’ diabetes data into best-in-class reporting and providing FDA cleared AI-powered personalized treatment recommendations which are clinically proven to optimize care and improve outcomes for patients with diabetes. Clinicians within NEMG have access to this powerful tool directly from the patient’s medical record by simply pressing an “endo.digital” button to seamlessly access the platform. The endo.digital system pushes critical patient information, such as glucose statistics, into the EMR flowsheet and progress notes. The patient’s approved care plan is delivered directly to the patient via the endo.digital patient app and/or email.

Lisa Stump, SVP, Chief Information and Digital Transformation Officer, YNHHS, said, “My organization deals with many technology vendors. Care for patients with diabetes adds to this challenge due to all the disparate diabetes devices required for these patients. This new technology will not only improve clinical operations but reduce the need for multiple integrations and installations by the IT team.”

Related Posts
1 of 40,993

Latest AI/NLP Technology Insights: ProcessUnity Acquires AI/NLP Technology from ISMS Solutions

Eran Atlas, CEO, DreaMed Diabetes, said, “We spent the last two years listening to clinicians and health system administrators, and the feedback was clear: EMR workflow integration is a must, and providers desire one platform integrated into their workflows that allows access to all the diabetes devices data their patients utilize and processes meaningful personalized clinical decision support recommendations they can trust. We believe the solution we have deployed at Yale New Haven Health will help transform the way its clinicians provide expert-level care to their patients with diabetes.”

Dr. Danielle Benaviv-Meskin, endocrinologist at NEMG said, “As an EMR integrated solution that covers most of the diabetes devices on the market, I can see an improvement to workflow efficiency in my endocrinology practice. And the inclusion of FDA-cleared decision support makes this the true one-stop-shop we have been looking for. ”

Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI

 [To share your insights with us, please write to sghosh@martechseries.com] 

Comments are closed.